Corundum Group, Inc. Merck & Co., Inc. Transaction History

Corundum Group, Inc.

$218 Million
Q3 2024

A detailed history of Corundum Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corundum Group, Inc. holds 10,654 shares of MRK stock, worth $1.03 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

10,654

Previous 16,979 37.25%

Holding current value

$1.03 Million

Previous $2.1 Million 42.48%

% of portfolio

0.55%

Previous 0.83%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $703,023 - $815,735	-6,325 Reduced 37.25%	10,654 $1.21 Million
Q2 2024 Jul 17, 2024	BUY	$123.8 - $132.96 $803,833 - $863,309	6,493 Added 61.92%	16,979 $2.1 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $146,079 - $170,215	1,290 Added 14.03%	10,486 $1.38 Million
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $258,965 - $281,816	-2,585 Reduced 21.94%	9,196 $1 Million
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $131,261 - $145,770	-1,275 Reduced 9.77%	11,781 $1.21 Million
Q2 2023 Jul 21, 2023	SELL	$108.61 - $118.38 $515,680 - $562,068	-4,748 Reduced 26.67%	13,056 $1.51 Million
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $514,700 - $574,300	5,000 Added 39.05%	17,804 $1.89 Million
Q4 2022 Jan 12, 2023	BUY	$87.44 - $112.11 $402,573 - $516,154	4,604 Added 56.15%	12,804 $1.42 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $32,290 - $36,274	382 Added 4.89%	8,200 $706,000
Q2 2022 Jul 25, 2022	BUY	$83.49 - $94.64 $75,141 - $85,176	900 Added 13.01%	7,818 $713,000
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $116,145 - $130,192	1,580 Added 29.6%	6,918 $568,000
Q4 2021 Feb 07, 2022	BUY	$72.28 - $90.54 $47,704 - $59,756	660 Added 14.11%	5,338 $409,000
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $65,587 - $72,129	915 Added 24.32%	4,678 $351,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $41,131 - $45,495	585 Added 18.41%	3,763 $293,000
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $6,059 - $7,137	88 Added 2.85%	3,178 $245,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $24,832 - $27,558	346 Added 12.61%	3,090 $253,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $200,805 - $227,614	2,744 New	2,744 $217,000
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $197,528 - $224,764	-2,805 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $177,724 - $246,335	2,805 New	2,805 $216,000
Q1 2020 May 06, 2020	SELL	$63.36 - $87.82 $194,008 - $268,904	-3,062 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $9,154 - $10,329	118 Added 4.01%	3,062 $278,000
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $223,979 - $244,145	2,944 New	2,944 $236,000
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $224,207 - $244,394	-2,947 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$69.84 - $81.59 $1,536 - $1,794	22 Added 0.75%	2,947 $247,000
Q1 2019 May 08, 2019	SELL	$69.58 - $79.36 $472,030 - $538,378	-6,784 Reduced 69.87%	2,925 $243,000
Q4 2018 Feb 19, 2019	BUY	$65.24 - $75.71 $633,415 - $735,068	9,709 New	9,709 $742,000

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.

Account

Corundum Group, Inc. Merck & Co., Inc. Transaction History